Firstly, γδ T cells express a wide repertoire of cell surface receptors conferring the ability to broadly recognize a diversity of tumor ligands and thereby target multiple tumor types, unlike HLA-restricted tumor recognition by αβ T cells. The gene discussed is CD177; the disease is neoplasm.